共 105 条
[1]
Maehama T(1998)The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate J. Biol. Chem. 273 13375-13378
[2]
Dixon JE(2008)PTEN: a new guardian of the genome Oncogene 27 5443-5453
[3]
Yin Y(2021)Cancer gene mutation frequencies for the U.S. population Nat. Commun. 212 103-116
[4]
Shen WH(2020)The clinical spectrum of PTEN mutation Annu. Rev. Med. 71 400-407
[5]
Mendiratta G(2012)Lifetime cancer risks in individuals with germline PTEN mutations Clin. Cancer Res. 18 844-860
[6]
Ke E(2019)PTEN Hamartoma Tumor Syndrome: A Clinical Overview Cancers 11 1387-1393
[7]
Aziz M(2020)Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome Eur. J. Hum. Genet. 28 219-225
[8]
Liarakos D(2021)A review on age-related cancer risks in PTEN hamartoma tumor syndrome Clin. Genet. 992 243-246
[9]
Tong M(2020)Occurrence and Natural History of Thyroid Cancer in Patients with Cowden Syndrome Eur. Thyroid J. 9 1189-1194
[10]
Stites EC(2013)Thyroid disease associated with Cowden syndrome: A meta-analysis Head. Neck 35 1-133